HESC study raises red flag; genetic link to bipolar disease;

Stem Cell Research

Scientists at Stanford say that human embryonic stem cells triggered an immune response in mice, raising fears of the potential side effects of any new stem cell therapies. Report

Cells obtained from menstrual blood, termed 'endometrial regenerative cells' (ERCs) are capable of restoring blood flow in an animal model of advanced peripheral artery disease. Release

Technology

Researchers have created a more efficient method for developing alkaloids, which are considered potentially useful for treating a range of diseases such as cancer, hypertension and autoimmune disorders. Report

Genetics

Genetic abnormalities have been linked with bipolar disease. Story

Scientists at Northwestern University's Feinberg School of Medicine have discovered a genetic trait present in 10 percent to 20 percent of patients with colorectal cancer. Report

Cancer Research

Scientists in the UK say that combining a drug for brittle bones with chemotherapy can have a dramatic effect on breast cancer. And a clinical trial is underway to determine if the drug should be made available relatively quickly. Story

Seeking to improve on nature, scientists used a spice-based compound as a starting point and developed synthetic molecules that, in lab settings, are able to kill cancer cells and stop the cells from spreading. Release

Suggested Articles

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.